Artiva Biotherapeutics (ARTV) Leases (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Leases for 3 consecutive years, with $212000.0 as the latest value for Q4 2025.
- For Q4 2025, Leases fell 18.77% year-over-year to $212000.0; the TTM value through Dec 2025 reached $212000.0, down 18.77%, while the annual FY2025 figure was $212000.0, 18.77% down from the prior year.
- Leases hit $212000.0 in Q4 2025 for Artiva Biotherapeutics, down from $11.3 million in the prior quarter.
- Across five years, Leases topped out at $16.5 million in Q4 2023 and bottomed at $212000.0 in Q4 2025.
- Average Leases over 3 years is $7.1 million, with a median of $5.8 million recorded in 2024.
- Year-over-year, Leases crashed 98.42% in 2024 and then soared 3980.43% in 2025.
- Artiva Biotherapeutics' Leases stood at $16.5 million in 2023, then plummeted by 98.42% to $261000.0 in 2024, then fell by 18.77% to $212000.0 in 2025.
- According to Business Quant data, Leases over the past three periods came in at $212000.0, $11.3 million, and $12.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.